Lupin receives USFDA approval for generic Liraglutide Injection and Glucagon, expanding access to diabetes treatments.

Mumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) ...

The US Food and Drug Administration has approved the first-ever generic glucagon injection kit for the treatment of severe hypoglycemia in patients with diabetes and as a diagnostic aid.. The FDA ...

Zealand Pharma submits New Drug Application to the U.S. Food and Drug Administration for the Dasiglucagon HypoPal ® Rescue Pen for treatment of severe hypoglycemia Copenhagen, March 31, 2020 ...

Xeris Pharmaceuticals announced the launch of Gvoke HypoPen™ (glucagon) for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 2 years and older.

Treatment . Hypoglycemia is treated using the 15-15 rule. ... susceptible to low blood sugar and should also talk with their doctor about carrying an emergency kit that contains a glucagon pen, ...

The FDA approved dasiglucagon as an auto injector or prefilled syringe for the treatment of severe hypoglycemia in people with diabetes aged 6 years and older, according to an industry press release.

Glucagon is a hormone that increases blood glucose levels in people with severe hypoglycemia. The medication can be taken in nasal spray form, or it can be injected into the skin.

It's early days, and further research is needed, but this proof-of-concept data indicates that the researchers’ glucagon-packed micelles are a promising treatment for insulin-induced hypoglycemia.

Glucagon is a hormone that signals the liver to release glucose into the bloodstream. It's typically given by injection to counteract severe hypoglycemia in people who have diabetes.

And while glucose-responsive insulin delivery systems are in widespread clinical use to treat insulin insufficiency, the on-demand supplementation of glucagon for acute hypoglycemia treatment isn ...

School personnel should soon be allowed to administer a new nasal spray used to treat severe hypoglycemia. In 2019, the Food and Drug Administration approved the use of Baqsimi nasal powder, the first ...